Nov 24, 2021, 13:46 PM by

InsightRX’s Precision Medicine Technology to Help Improve Care for Patients Receiving Stem Cell Transplants

Nov 24, 2021, 13:46 PM by

Stilla Technologies, the multiplex digital PCR company, has secured more than €31 million in new financing, adding Casdin Capital and the European Investment Bank (EIB) in addition to new funding from existing investors Illumina Ventures, Kurma Partners, TusPark Capital Management (Luxembourg) S.à r.l., LBO France, BNP Paribas Développement, and Eurazeo.

Nov 24, 2021, 13:46 PM by

Applied BioMath, the industry-leader in providing model-informed drug discovery and development (MID3) support to help accelerate and de-risk therapeutic research and development (R&D), was listed as one of the top ten biosimulation solution companies for 2021 by Pharma Tech Outlook.

Nov 23, 2021, 01:00 AM by User Not Found

Bio-IT World | Genomics and artificial intelligence (AI) are key to this quest and at-scale advancement of personalized medicine. Both, however, require liquid data and modern data infrastructure that re-imagines the role of data and how it is used.

Nov 22, 2021, 01:00 AM by User Not Found

Bio-IT World | Evidence has been mounting for decades that what men eat can lower or raise their risk of prostate cancer—including aggressive forms of the disease that can be lethal. But that’s only part of the story.

Nov 19, 2021, 19:34 PM by

In a study that builds on earlier research that identified macrophages as essential to regeneration in the axolotl, a highly regenerative salamander, James Godwin, Ph.D., a scientist at the MDI Biological Laboratory in Bar Harbor, Maine, has identified the source of these critical white blood cells as the liver. By giving scientists a place to look for pro-regenerative macrophages in humans, the discovery brings science a step closer to being able to regenerate tissues and organs lost to injury or disease in humans.

Nov 19, 2021, 19:34 PM by

Nov 19, 2021, 19:34 PM by

Watson-Marlow Fluid Technology Group announces it has been named Most Innovative Pharma Fluid Management Solutions Provider 2021 at the Global Health and Pharma Healthcare and Pharmaceutical Awards.

Nov 19, 2021, 19:34 PM by

Anju Software has announced that Steve Rosenberg, an industry leader and innovator in developing and deploying patient-centric clinical trial technologies, has joined the company's Board of Directors. Rosenberg also formerly led Oracle's clinical software business.

Nov 19, 2021, 19:34 PM by

Nov 19, 2021, 19:34 PM by

Nov 19, 2021, 19:34 PM by

Singapore-based viral vector CDMO CellVec announces today that it has been selected as the manufacturer of choice for Australian cell therapy immuno-oncology company Carina Biotech, undertaking the production of GMP-compliant lentivirus constructs for its LGR5 CAR-T. The partnership is slated to advance clinical trials for a treatment designed for patients with advanced colorectal (bowel) cancer.

Nov 19, 2021, 19:34 PM by

Pharma veteran Mike Petrarca joins physIQ to drive revenue growth in the life sciences continuum; Chris Economos to advance strategic partnerships

Nov 19, 2021, 19:34 PM by

Pure's Evergreen Storage subscription allows TrialStat to upgrade its storage with no disruptions

Nov 19, 2021, 19:34 PM by

Well Pharmacy has joined forces with the charity Antibiotic Research UK for World Antimicrobial Awareness Week (WAAW) to encourage patients to be antibiotics aware this winter to drive better health outcomes in the communities they serve.

Nov 19, 2021, 19:34 PM by

UHN drives Canadian effort for international genomics and health data sharing standards

Nov 19, 2021, 01:00 AM by User Not Found

Bio-IT World | Worldwide spending on pharmaceutical R&D will reach $230 billion by 2026. So with investment dollars flowing in and R&D continuing an upward trajectory all should be well, right? Well… not exactly. Like many industries, pharmaceutical companies are facing a data problem—a dark data problem.

Nov 17, 2021, 01:00 AM by User Not Found

Bio-IT World | As a “digital native,” Recursion is working to reshape the drug discovery industry—quite literally. Gone is the vision of a traditional discovery funnel, wide at the top and slowly narrowing. Instead, Recursion proposes a drug discovery machine powering a T-shaped funnel where many options are considered, but failure is fast and the candidates that advance have a potentially higher likelihood of being a successful treatment. Easier said than done.

Nov 16, 2021, 15:21 PM by

Nov 16, 2021, 15:21 PM by